Wu, Ke
Yan, Meisi
Liu, Tong http://orcid.org/0000-0001-9234-1328
Wang, Zheng
Duan, Yuran
Xia, Yan
Ji, Guimei
Shen, Yuli
Wang, Lei
Li, Lin
Zheng, Peixiang
Dong, Bofei
Wu, Qingang
Xiao, Liwei
Yang, Xueying
Shen, Haochen
Wen, Ting
Zhang, Jingjing
Yi, Jinfeng
Deng, Yuhan
Qian, Xu
Ma, Leina http://orcid.org/0000-0003-3964-632X
Fang, Jing
Zhou, Qin http://orcid.org/0000-0003-3879-4021
Lu, Zhimin http://orcid.org/0000-0002-2859-2736
Xu, Daqian http://orcid.org/0000-0003-0478-2997
Funding for this research was provided by:
National Natural Science Foundation of China (82030074, 82072630)
Article History
Received: 29 December 2021
Accepted: 21 March 2023
First Online: 8 May 2023
Competing interests
: Z.L. owns shares in Signalway Biotechnology (Pearland, TX), which supplied rabbit antibodies that recognize CKB pT133 and GPX4 pS104. Z.L.’s interest in this company had no bearing on its being chosen to supply these reagents. The other authors declare no competing interests.